The degree of frailty as a translational measure of health in aging

SE Howlett, AD Rutenberg, K Rockwood - Nature Aging, 2021 - nature.com
Frailty is a multiply determined, age-related state of increased risk for adverse health
outcomes. We review how the degree of frailty conditions the development of late-life …

Frailty screening and interventions: considerations for clinical practice

J Walston, B Buta, QL Xue - Clinics in geriatric medicine, 2018 - geriatric.theclinics.com
Over the past 100 years, advances in medicine and public health have led to a nearly 2-fold
increase in average lifespan. 1 Approximately 8.5% of the global population is 65 years or …

Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial

JH Butt, PS Jhund, J Belohlávek, RA De Boer… - Circulation, 2022 - Am Heart Assoc
Background: Frailty is increasing in prevalence. Because patients with frailty are often
perceived to have a less favorable risk/benefit profile, they may be less likely to receive new …

Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged≥ 75 years: a randomized clinical trial

JD Williamson, MA Supiano, WB Applegate… - Jama, 2016 - jamanetwork.com
Importance The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain. Objective To evaluate the effects of intensive …

Longer-term all-cause and cardiovascular mortality with intensive blood pressure control: a secondary analysis of a randomized clinical trial

BC Jaeger, AP Bress, JD Bundy, AK Cheung… - JAMA …, 2022 - jamanetwork.com
Importance The Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive
blood pressure control reduced cardiovascular morbidity and mortality. However, the legacy …

[HTML][HTML] Effect of intensive blood-pressure treatment on patient-reported outcomes

DR Berlowitz, CG Foy, LE Kazis, LP Bolin… - … England Journal of …, 2017 - Mass Medical Soc
Background The previously published results of the Systolic Blood Pressure Intervention
Trial showed that among participants with hypertension and an increased cardiovascular …

Sacubitril/valsartan and frailty in patients with heart failure and preserved ejection fraction

JH Butt, P Dewan, PS Jhund, IS Anand, D Atar… - Journal of the American …, 2022 - jacc.org
Background Frailty is an increasingly common problem, and frail patients are less likely to
receive new pharmacologic therapies because the risk–benefit profile is perceived to be …

Effect of vitamin D3 and omega-3 fatty acid supplementation on risk of frailty: an ancillary study of a randomized clinical trial

AR Orkaby, R Dushkes, R Ward, L Djousse… - JAMA network …, 2022 - jamanetwork.com
Importance Preventive strategies for frailty are needed. Whether supplements with anti-
inflammatory properties, such as vitamin D 3 or marine omega-3 fatty acids, are useful for …

Systolic blood pressure trajectory, frailty, and all-cause mortality> 80 years of age: cohort study using electronic health records

R Ravindrarajah, NC Hazra, S Hamada, J Charlton… - Circulation, 2017 - Am Heart Assoc
Background: Clinical trials show benefit from lowering systolic blood pressure (SBP) in
people≥ 80 years of age, but nonrandomized epidemiological studies suggest lower SBP …

The frailty syndrome and outcomes in the TOPCAT trial

NA Sanders, MA Supiano, EF Lewis… - European journal of …, 2018 - Wiley Online Library
Aims The impact of frailty on outcomes in randomized heart failure with preserved ejection
fraction (HFpEF) trials has not been previously reported. This analysis sought to characterize …